Page 178 - MI-2-3
P. 178

Microbes & Immunity                                     A novel anti-EphB2 monoclonal antibody for flow cytometry



            G418. This process resulted in the establishment of the   2.4. Flow cytometric analysis
            Eph receptors-overexpressed CHO-K1 (e.g., CHO/EphB2)   Cells were harvested following brief exposure to 0.25%
            clones. In addition, the CHO/PA16-EphB4 cell line had   trypsin and 1 mM ethylenediaminetetraacetic acid
            been previously established. 43
                                                               (Nacalai Tesque, Inc., Japan). After trypsinization, the
              CHO-K1     cells,  Eph   receptors-overexpressed  cells were washed with 0.1% bovine serum albumin in
            CHO-K1  cells, and P3U1  cells were cultured in a   PBS (blocking buffer) and treated with 0.01, 0.1, 1, and
            Roswell Park Memorial Institute (RPMI)-1640 medium   10 μg/mL of primary mAbs for 30 min at 4°C. Subsequently,
            (Nacalai Tesque, Inc., Japan), supplemented with 10%   the cells were treated with Alexa Fluor 488-conjugated
            heat-inactivated fetal bovine serum (FBS; Thermo   anti-mouse IgG (1:2,000). In addition, the cells were
            Fisher  Scientific  Inc.,  USA),  100  units/mL  of  penicillin,   suspended in 0.01, 0.1, 1, and 10  μg/mL concentrations
            100  μg/mL of streptomycin, and 0.25  μg/mL of     of the 2H9. Fluorescence data were collected using the
            amphotericin  B (Nacalai  Tesque, Inc., Japan).  LS174T,   SA3800 Cell Analyzer (Sony Corp). Cells were gated on
            LN229, and EphB2-overexpressed LN229 (LN229/EphB2)   the dot plot based on side scatter and forward scatter, and
            cells were cultured in Dulbecco’s Modified Eagle Medium   the fluorescence intensity was determined using FlowJo
            (Nacalai Tesque, Inc., Japan), supplemented with 10%   software (BD Biosciences, USA).
            FBS, 100 units/mL of penicillin, 100 μg/mL streptomycin,
            and 0.25 μg/mL amphotericin B. All cells were grown in   2.5. Determination of dissociation constant (K ) by
                                                                                                       D
            a humidified incubator at 37°C with an atmosphere of 5%   flow cytometry
            CO  and 95% air.                                   CHO/EphB2 and LS174T cells were suspended in serially-
               2
                                                               diluted Eb Mabs for 30 min at 4°C. The cells were treated
            2.3. Development of hybridomas                             2
                                                               with Alexa Fluor 488-conjugated anti-mouse IgG (1:200).
            The animals were housed under specific pathogen-free   The cells were suspended in serially diluted 2H9 conjugated
            conditions. All animal experiments were approved by the   with RB545. Fluorescence data were collected using the BD
            Animal Care and Use Committee of Tohoku University   FACSLyric (BD Biosciences, USA). The K  was calculated
                                                                                                D
            (Permit number: 2022MdA-001).                      by fitting saturation binding curves to the built-in one-
              Two 5-week-old BALB/cAJcl mice were purchased    site binding models in  GraphPad PRISM 6 (GraphPad
            from CLEA Japan (Japan) to develop mAbs against EphB2.   Software, USA).
            The immunization protocol involved intraperitoneal   3. Results
            administration of LN229/EphB2  (1 × 10   cells) mixed
                                               8
            with 2% Alhydrogel adjuvant (InvivoGen, USA). This   3.1. Development of anti-EphB2 mAbs using the
            initial immunization was followed by 3 additional weekly   CBIS method
            injections (1  × 10   cells/mouse),  culminating in  a final   Mice were immunized with LN229/EphB2 cells to develop
                           8
            booster intraperitoneal injection (1 × 10   cells/mouse)   anti-EphB2 mAb (Figure  1A). The spleen was excised,
                                               8
            2  days before harvesting spleen cells. The harvested   and  splenocytes  were  fused  with  myeloma  P3U1  cells
            spleen cells were subsequently fused with P3U1  cells   (Figure 1B). The developed hybridomas were subsequently
            using PEG1500 (Roche Diagnostics, USA). Hybridomas   seeded into ten 96-well plates and cultivated for 6 days.
            were  cultured  in  the  RPMI-1640  medium  with  10%   The positive wells were screened by selecting CHO/
            FBS, 5% BriClone (NICB, Ireland), 100 units/mL of   EphB2-reactive and CHO-K1-non-reactive supernatants
            penicillin, 100 μg/mL of streptomycin, and 0.25 μg/mL of   using flow cytometry (Figure 1C). A total of 133 positive
            amphotericin B. For hybridoma selection, hypoxanthine,   wells (13.9%) out of 956 wells were obtained. After limiting
            aminopterin,  and  thymidine  (Thermo  Fisher  Scientific   the dilution of the positive wells and several additional
            Inc., USA) were added to the medium. The supernatants   screenings, 12 clones were finally established (Figure 1D).
            were subsequently screened using flow cytometry with
            CHO/EphB2 and CHO-K1 cells.                        3.2. Flow cytometric analysis using anti-EphB2
              The cultured supernatant of Eb Mab hybridomas was   mAbs
                                        2
            then applied to 1 mL of Ab-Capcher (ProteNova, Japan).   Eight mouse IgG  clones (Eb Mab-1, 2, 3, 4, 7, 8, 10, and
                                                                             1
                                                                                      2
            After washing with phosphate-buffered saline (PBS), the   12) were selected, and the mAbs were purified from the
            antibodies were eluted with an IgG elution buffer (Thermo   supernatants (Table 1). The specificity of Eb Mabs and 2H9
                                                                                                 2
            Fisher Scientific Inc., USA). Finally, the eluates were   in  14 Eph receptor  tyrosine  kinases-expressed  CHO-K1
            concentrated, and the elution buffer was replaced with PBS   was were investigated. 2H9 exhibited reactivity to not only
            using Amicon Ultra (Merck KGaA, Germany).          CHO/EphB2 but also to CHO/EphA4, CHO/EphB1, and

            Volume 2 Issue 3 (2025)                        170                               doi: 10.36922/mi.5728
   173   174   175   176   177   178   179   180   181   182   183